Intraoperative examination of the sentinel lymph node for breast carcinoma staging

Roderick R. Turner*, Nora M. Hansen, Stacey L. Stern, Armando E. Giuliano

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

132 Scopus citations

Abstract

Intraoperative pathologic examination of the sentinel lymph node (SLN) draining a primary breast carcinoma allows an SLN-positive patient to undergo complete axillary lymphadenectomy as part of the same surgical procedure. However, the optimal technique for rapid SLN assessment has not been determined. We reviewed our results with imprint cytology (IC) and frozen section (FS) examination of SLNs from 278 patients. Compared with H and E- stained paraffin sections, IC and FS had an overall accuracy of 93.2%. The false-reassurance rate (false-negative results/all negative results) was 8.4%. It correctly identified 98% of macrometastases but only 28% of micrometastases. There were no false-positive results. Compared with paraffin-section cytokeratin immunohistochemistry results, the IC-FS false- reassurance rate increased to 25.8%. The false-reassurance rate decreased with smaller primary tumor size (T1 vs T2/3) and ductal type, smaller diameter of the SLN (≤2.0 cm), and greater pathologist experience. IC combined with 2-level FS reliably identifies SLN macrometastases but commonly fails to detect SLN micrometastases. If SLN micrometastasis is used to determine the need for further lymphadenectomy, more sensitive intraoperative methods will be needed to avoid a second operation.

Original languageEnglish (US)
Pages (from-to)627-634
Number of pages8
JournalAmerican journal of clinical pathology
Volume112
Issue number5
DOIs
StatePublished - 1999

Keywords

  • Breast carcinoma
  • Frozen section
  • Immunohistochemistry
  • Imprint cytology
  • Sentinel lymph node

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Intraoperative examination of the sentinel lymph node for breast carcinoma staging'. Together they form a unique fingerprint.

Cite this